Evidence map›Paper›PMID 40498650›Full record

ArticleHuman vaccines & immunotherapeutics2025

Young adult perspectives on deciding to get human papillomavirus (HPV) vaccination in urban and rural communities: A qualitative research study.

Maria E Sundaram, Ben Christianson, Oluwakemi D Alonge, Melody Doan, Hanna Ljungman, Elizabeth Polter, Anne Steinberg, Casper G Bendixsen, Charnetta L Williams, Edward A Belongia and 2 more

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maria E SundaramMarshfield Clinic Research Institute, Marshfield, WI, USA.ORCID 0000-0001-8056-3302
Ben ChristiansonMinnesota Department of Health, St. Paul, MN, USA.
Oluwakemi D AlongeMarshfield Clinic Research Institute, Marshfield, WI, USA.ORCID 0000-0002-0363-6229
Melody DoanImmunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0009-0002-0057-0698
Hanna LjungmanMinnesota Department of Health, St. Paul, MN, USA.
Elizabeth PolterMinnesota Department of Health, St. Paul, MN, USA.ORCID 0000-0001-7336-3492
Anne SteinbergMinnesota Department of Health, St. Paul, MN, USA.
Casper G BendixsenNational Farm Medicine Center, Marshfield Clinic Research Institute, Marshfield, WI, USA.ORCID 0000-0002-3419-6940
Charnetta L WilliamsImmunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Edward A BelongiaMarshfield Clinic Research Institute, Marshfield, WI, USA.ORCID 0000-0001-7478-0415
Huong Q NguyenMarshfield Clinic Research Institute, Marshfield, WI, USA.ORCID 0000-0003-2725-6439
Jeffrey J VanWormerMarshfield Clinic Research Institute, Marshfield, WI, USA.ORCID 0000-0002-8733-8703

Funding

NCIRD CDC HHS U01 IP001093
6 · The paper itself

Abstract

Human papillomavirus (HPV) vaccination coverage in the US is lower than other recommended adolescent vaccines. Coverage is consistently lower in rural areas, compared to urban areas. Despite this, there exists relatively little evidence on perspectives of HPV vaccination during adolescence/young adulthood. We conducted 56 interviews with young adults about their experiences, perspectives, and decision-making with HPV vaccination. Young adults aged 18-21 years who, as adolescents, may have initially refused or delayed (or their parents may have refused or delayed) and subsequently accepted HPV vaccination who resided in rural Wisconsin or urban Minnesota were eligible to participate. Interviews included questions and prompts about decision-making processes and perspectives about HPV vaccination, such as "How did you feel about the HPV vaccine before you got vaccinated?" and "What changes happened that factored into you getting the shot?" In a thematic analysis, young adults valued: information-gathering about vaccines, the opportunity to make vaccine decisions on their own (or with support of parents), and a trusting relationship with their healthcare provider. They expressed a wide range of perspectives on vaccine acceptance and hesitancy. Young adults were more concerned about needles, pain, and discomfort than other adverse outcomes following vaccination. A higher proportion of young adults in urban areas (compared to rural areas) mentioned the importance of trust in their healthcare provider. Strategies to increase HPV vaccine uptake and acceptance may consider young adults' perspectives, including the importance of the information-gathering process and relationships with their healthcare providers.

Indexed as

Decision MakingPapillomavirus InfectionsPapillomavirus VaccinesPatient Acceptance of Health CareVaccinationAdolescentAdultFemaleHealth Knowledge, Attitudes, PracticeHuman Papillomavirus VirusesHumansInterviews as TopicMaleMinnesotaQualitative ResearchRural PopulationPapillomavirus Vaccineshuman papillomavirus vaccinerural populationurban populationVaccine hesitancyyoung adults

Identifiers

PMID40498650
PMCPMC12160599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.